These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9092411)

  • 21. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newer antiplatelet therapies in stroke prevention.
    Davis SM; Donnan GA
    Aust Fam Physician; 2001 Feb; 30(2):129-34. PubMed ID: 11280112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of ticlopidine monotherapy versus ticlopidine and aspirin after coronary artery stenting: follow-up results of a randomized study.
    Machraoui A; Germing A; Lindstaedt M; von Dryander S; Bojara W; Lawo T; Lemke B; Jaeger D; Grewe P; Deneke T; Barmeyer J
    J Invasive Cardiol; 2001 Jun; 13(6):431-6. PubMed ID: 11385163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
    Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
    Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
    Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina.
    Bierbach B; Horstick G; Berg O; Heimann A; Münzel T; Vahl CF; Kempski O; Darius H
    Thromb Haemost; 2006 Feb; 95(2):354-61. PubMed ID: 16502561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability in platelet response to the antiplatelet agents aspirin and clopidogrel: mechanisms, measurement, and clinical relevance.
    Jennings LK
    Crit Pathw Cardiol; 2009 Mar; 8(1):20-8. PubMed ID: 19258834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].
    Iturbe T; Sánchez C; Moreno JA; Olave T; Azaceta G; Varo MJ; Civeira E; Peleato J; Cornudella R
    Sangre (Barc); 1997 Oct; 42(5):387-90. PubMed ID: 9424739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
    Lepäntalo A; Virtanen KS; Reséndiz JC; Mikkelsson J; Viiri LE; Karhunen PJ; Lassila R
    Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet agents in acute coronary syndromes.
    Eikelboom JW; Anand S
    Semin Vasc Med; 2003 Nov; 3(4):403-14. PubMed ID: 15199447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
    Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation.
    Goto S; Tamura N; Sakakibara M; Ikeda Y; Handa S
    Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Blood platelet aggregation inhibitors in the treatment of heart diseases].
    Verheugt FW
    Ned Tijdschr Geneeskd; 1993 Aug; 137(33):1647-50. PubMed ID: 8371794
    [No Abstract]   [Full Text] [Related]  

  • 35. [Anti-aggregation therapy of patients with ischemic heart disease].
    Liusov VA; Savenkov MP
    Ter Arkh; 1988; 60(8):55-9. PubMed ID: 3227479
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical evaluation of the control of antiplatelet therapy through platelet aggregation rate on polycythemia vera associated with thrombocytosis and erythromelalgia].
    Kurihara A; Kobayashi I; Tamura K
    Rinsho Ketsueki; 1989 Jan; 30(1):99-104. PubMed ID: 2716205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiplatelet drugs and prevention of aortocoronary bypass occlusion].
    Davì G; Botindari G; Catalano I; Strano A
    Cardiologia; 1988 Feb; 33(2):123-6. PubMed ID: 3282656
    [No Abstract]   [Full Text] [Related]  

  • 38. Antiplatelet therapy.
    Schafer AI
    Am J Med; 1996 Aug; 101(2):199-209. PubMed ID: 8757361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the combination of antiplatelet agents in man: combination of aspirin, trapidil, ticlopidine and dipyridamole.
    Nagakawa Y; Akedo Y; Orimo H; Yano H
    Thromb Res; 1990 Dec; 60(6):469-75. PubMed ID: 2082479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiplatelet therapy.
    Sloan RW
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.